Sex differences and sex steroids influence on the presentation and severity of cardiovascular autonomic neuropathy of patients with type 1 diabetes

被引:7
|
作者
Nattero-Chavez, Lia [1 ,2 ]
Insenser, Maria [2 ]
Tobar, Alejandra Quintero [2 ]
Fernandez-Duran, Elena [2 ]
Avendano, Beatriz Dorado [1 ]
Fiers, Tom [3 ,4 ]
Kaufman, Jean-Marc [3 ,4 ]
Luque-Ramirez, Manuel [1 ,2 ,5 ]
Escobar-Morreale, Hector F. [1 ,3 ,4 ,5 ]
机构
[1] Hosp Univ Ramon y Cajal, Dept Endocrinol & Nutr, Carretera Colmenar,Km 9-1, Madrid 28034, Spain
[2] Inst Salud Carlos III, Diabet Obes & Human Reprod Res Grp, Inst Ramon y Cajal Invest Sanitaria IRYCIS, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain
[3] Ghent Univ Hosp, Lab Hormonol, B-9000 Ghent, Belgium
[4] Ghent Univ Hosp, Dept Endocrinol, B-9000 Ghent, Belgium
[5] Univ Alcala, Madrid, Spain
关键词
Autonomic nervous system; Cardiovascular disease; Cardioautonomic neuropathy; Sexual dimorphism; Sex differences; Sex hormones; Sex steroids; Type 1 diabetes mellitus; SYMPATHETIC-NERVE ACTIVITY; BAROREFLEX SENSITIVITY; INSULIN-RESISTANCE; NEURAL-CONTROL; TESTOSTERONE; RISK; PREVALENCE; STATEMENT; DIAGNOSIS; CAPACITY;
D O I
10.1186/s12933-023-01766-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundSex differences characterize cardiovascular outcomes in patients with type 1 diabetes. Cardioautonomic neuropathy is a common complication of type 1 diabetes that associates increased morbi-mortality. Data regarding the interplay between sex and cardiovascular autonomic neuropathy are scarce and controversial in these patients. We aimed to address sex-related differences in the prevalence of seemingly asymptomatic cardioautonomic neuropathy in type 1 diabetes, and their associations with sex steroids.MethodsWe conducted a cross-sectional study including 322 consecutively recruited patients with type 1 diabetes. Cardioautonomic neuropathy was diagnosed using Ewing's score and power spectral heart rate data. We assessed sex hormones by liquid chromatography/tandem mass spectrometry.ResultsWhen considering all subjects as a whole, asymptomatic cardioautonomic neuropathy prevalence was not significantly different between women and men. When age was taken into account, the prevalence of cardioautonomic neuropathy was similar among young men and those > 50 years. However, in women > 50 years, the prevalence of cardioautonomic neuropathy doubled that of young women [45.8% (32.6; 59.7) vs. 20.4% (13.7; 29.2), respectively]. The OR of having cardioautonomic neuropathy was 3.3 higher in women > 50 years than in their younger counterparts. Furthermore, women presented more severe cardioautonomic neuropathy than men. These differences were even more marked when women were classified according their menopausal status instead of age. Peri- and menopausal women had an OR 3.5 (1.7; 7.2) of having CAN compared with their reproductive-aged counterparts [CAN prevalence: 51% (37; 65) vs. 23% (16; 32), respectively]. A binary logistic regression model (R-2: 0.161; P = 0.001) displayed age > 50 years as a significant determinant of cardioautonomic neuropathy only in women. Androgens were positively associated with heart rate variability in men, and negatively in women. Accordingly, cardioautonomic neuropathy was associated with increased testosterone/estradiol ratio in women but to decreased testosterone concentrations in men.ConclusionsMenopause in women with type 1 diabetes is accompanied by an increase in the prevalence of asymptomatic cardioautonomic neuropathy. This age-related excess risk of cardioautonomic neuropathy is not observed in men. Men and women with type 1 diabetes have opposite associations between circulating androgens and indexes of cardioautonomic function.Trial registration ClinicalTrials.gov Identifier: NCT04950634.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Leptin mediate central obesity on the severity of cardiovascular autonomic neuropathy in well-controlled type 2 diabetes and prediabetes
    Lai, Yun-Ru
    Chen, Meng Hsiang
    Lin, Wei Che
    Chiu, Wen-Chan
    Cheng, Ben-Chung
    Chen, Jung-Fu
    Tsai, Nai-Wen
    Huang, Chih-Cheng
    Lu, Cheng-Hsien
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [32] Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus
    Pafili, Kalliopi
    Trypsianis, Grigorios
    Papazoglou, Dimitrios
    Maltezos, Efstratios
    Papanas, Nikolaos
    DIABETES THERAPY, 2020, 11 (04) : 979 - 986
  • [33] Racial and ethnic differences in cardiovascular disease and outcome in type 1 diabetes patients
    Ali, Mohammed T.
    Al Suwaidi, Jassim
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2019, 14 (04) : 225 - 231
  • [34] Clinical scoring systems for the risk of cardiovascular autonomic neuropathy in type 1 and type 2 diabetes: A simple tool
    Menduni, Marika
    D'Amato, Cinzia
    Leoni, Martina
    Izzo, Valentina
    Staltari, Mariateresa
    Greco, Carla
    Abbatepassero, Andrea
    Seminara, Giuseppe
    D'Ippolito, Ilenia
    Lauro, Davide
    Spallone, Vincenza
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 (04) : 259 - 270
  • [35] Cardiovascular autonomic neuropathy and charcot neuroarthropathy in type 2 diabetes: adding a new severity classification score
    de Vasconcelos, Jessica Castro
    Atala, Yeelen Ballesteros
    Zantut-Wittmann, Denise Engelbrecht
    Parisi, Maria Candida Ribeiro
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2025, 45 (01) : 40 - 46
  • [36] Diabetic Retinopathy Is Strongly Predictive of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes
    Huang, Chih-Cheng
    Lee, Jong-Jer
    Lin, Tsu-Kung
    Tsai, Nai-Wen
    Huang, Chi-Ren
    Chen, Shu-Fang
    Lu, Cheng-Hsien
    Liu, Rue-Tsuan
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [37] Insulin resistance is independently associated with cardiovascular autonomic neuropathy in type 2 diabetes
    Liu, Yingshan
    Peng, Yu
    Jin, Jing
    Chen, Yanshan
    Chen, Chuna
    Chen, Zhenguo
    Huang, Haishan
    Xu, Lingling
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (09) : 1651 - 1662
  • [38] Sex Differences in Type-2 Diabetes: Implications for Cardiovascular Risk Management
    Raparelli, Valeria
    Morano, Susanna
    Franconi, Flavia
    Lenzi, Andrea
    Basili, Stefania
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (10) : 1471 - 1476
  • [39] Sex differences in vascular stiffness and relationship to the risk of renal functional decline in patients with type 2 diabetes
    Earle, Kenneth A.
    Ng, Lauren
    White, Sarah
    Zitouni, Karima
    DIABETES & VASCULAR DISEASE RESEARCH, 2017, 14 (04) : 304 - 309
  • [40] Bone turnover markers in patients with prostate carcinoma: influence of sex steroids levels
    Varsavsky, Mariela
    Reyes-Garcia, Rebeca
    Garcia-Martin, Antonia
    Rozas-Moreno, Pedro
    Rocio, Gonzalez-Ramirez
    Munoz-Torres, Manuel
    JOURNAL OF BONE AND MINERAL METABOLISM, 2014, 32 (01) : 65 - 70